Prognostic Impact of FoxP3+ Regulatory T Cells in Relation to CD8+ T Lymphocyte Density in Human Colon Carcinomas

Open Access

Peer-reviewed

Research Article

Harry H. Yoon,

Affiliation Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Jared M. Orrock,

Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Nathan R. Foster,

Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Daniel J. Sargent,

Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Thomas C. Smyrk,

Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Frank A. Sinicrope

* E-mail: Sinicrope.frank@mayo.edu

Affiliations Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Reader Comments (0)

Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Regulatory T cells
Is the Subject Area "Regulatory T cells" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Carcinoma
Is the Subject Area "Carcinoma" applicable to this article?

Thanks for your feedback.
Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.